UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer

The Journal of clinical investigation, 2022-08, Vol.132 (15)

2022

Volltextzugriff (PDF)

Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis

Cancers, 2024-01, Vol.16 (2), p.404

2024

Volltextzugriff (PDF)

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Frontiers in oncology, 2021-07, Vol.11, p.707050-707050

2021

Volltextzugriff (PDF)

Examining the Effect of ALK and EGFR Mutations on Survival Outcomes in Surgical Lung Brain Metastasis Patients

Cancers, 2023-09, Vol.15 (19), p.4773

2023

Volltextzugriff (PDF)

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in oncology, 2021-06, Vol.11, p.701345-701345

2021

Volltextzugriff (PDF)

18 Systemic immune profiling of advanced biliary tract cancer patients defines altered cytokines and immune cell populations

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A20-A20

2021

Volltextzugriff (PDF)

Differences in preoperative frailty assessment of surgical candidates by sex, age, and race

Surgery open science, 2024-06, Vol.19, p.172-177

2024

Volltextzugriff (PDF)

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology, 2022-08, Vol.5 (3), p.52-57

2022

Volltextzugriff (PDF)

Construct validation and comparison of a novel postoperative quality-of-life metric and the Short Form-36 in colorectal surgery patients

Surgery, 2013-10, Vol.154 (4), p.690-696

2013

Volltextzugriff (PDF)

44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A45-A46

2020

Volltextzugriff (PDF)

223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A242-A242

2020

Volltextzugriff (PDF)

45 Body composition as a predictive and prognostic biomarker in advanced urothelial carcinoma (UC) patients treated with immune checkpoint inhibitors (ICI)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A47-A48

2020

Volltextzugriff (PDF)

Reply to: Regarding the Simple Preoperative Imaging Measurements Predict Postoperative Pancreatic Fistula After Pancreatoduodenectomy

Annals of surgical oncology, 2024-08, Vol.31 (8), p.5009-5010

2024

Volltextzugriff (PDF)

Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer

Journal of surgical oncology, 2023-12, Vol.128 (8), p.1461-1463

2023

Volltextzugriff (PDF)

Dexamethasone and brain metastasis-infiltrating CD8+ T cells

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15075-e15075

2022

Volltextzugriff (PDF)

Treatment Patterns and Clinical Outcomes of Patients with Sézary Syndrome at Emory University

Blood, 2020-11, Vol.136 (Supplement 1), p.22-23

2020

Volltextzugriff (PDF)

Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience

Modern pathology, 2023-09, Vol.36 (9), p.100235-100235, Article 100235

2023

Volltextzugriff (PDF)

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

The Journal of clinical investigation, 2021-12, Vol.131 (24), p.1-10

2021

Volltextzugriff (PDF)

Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.11-11

2023

Volltextzugriff (PDF)

Time to first treatment and optimal adjuvant treatment strategy in patients with resectable gastric cancer pathologically upstaged to lymph node–positive disease

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.473-473

2023

Volltextzugriff (PDF)

Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.e2061-e2069

2021

Volltextzugriff (PDF)

Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report

Clinical lung cancer, 2024-03, Vol.25 (2), p.180-185.e1

2024

Volltextzugriff (PDF)

Defining the Reliability of Bladder Scan in Obese Patients with Postoperative Urinary Retention

Journal of the American College of Surgeons, 2022-11, Vol.235 (5), p.S24-S25

2022

Volltextzugriff (PDF)

Characteristics and outcomes of patients with multiple synchronous colon cancer primaries

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.194-194

2022

Volltextzugriff (PDF)

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Blood cancer journal (New York), 2019-11, Vol.9 (12), p.94-13, Article 94

2019

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer

Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Examining the Effect of ALK and EGFR Mutations on Survival Outcomes in Surgical Lung Brain Metastasis Patients

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

18 Systemic immune profiling of advanced biliary tract cancer patients defines altered cytokines and immune cell populations

Differences in preoperative frailty assessment of surgical candidates by sex, age, and race

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Construct validation and comparison of a novel postoperative quality-of-life metric and the Short Form-36 in colorectal surgery patients

44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)

223 Racial differences in outcomes for metastatic renal cell carcinoma (mRCC) patients managed on immune-checkpoint inhibitor (ICI) therapy

45 Body composition as a predictive and prognostic biomarker in advanced urothelial carcinoma (UC) patients treated with immune checkpoint inhibitors (ICI)

Reply to: Regarding the Simple Preoperative Imaging Measurements Predict Postoperative Pancreatic Fistula After Pancreatoduodenectomy

Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer

Dexamethasone and brain metastasis-infiltrating CD8+ T cells

Treatment Patterns and Clinical Outcomes of Patients with Sézary Syndrome at Emory University

Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI)

Time to first treatment and optimal adjuvant treatment strategy in patients with resectable gastric cancer pathologically upstaged to lymph node–positive disease

Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and Anticoagulation

Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report

Defining the Reliability of Bladder Scan in Obese Patients with Postoperative Urinary Retention

Characteristics and outcomes of patients with multiple synchronous colon cancer primaries

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Suchergebnisse filtern